Cell therapy: types, regulation, and clinical benefits

AEH El-Kadiry, M Rafei, R Shammaa - Frontiers in Medicine, 2021 - frontiersin.org
Cell therapy practices date back to the 19th century and continue to expand on
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …

The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes

P Krzyszczyk, R Schloss, A Palmer… - Frontiers in …, 2018 - frontiersin.org
Macrophages play key roles in all phases of adult wound healing, which are inflammation,
proliferation, and remodeling. As wounds heal, the local macrophage population transitions …

A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing

H Liu, C Wang, C Li, Y Qin, Z Wang, F Yang, Z Li… - RSC …, 2018 - pubs.rsc.org
Functional active wound dressings are expected to provide a moist wound environment,
offer protection from secondary infections, remove wound exudate and accelerate tissue …

The treatment of impaired wound healing in diabetes: looking among old drugs

SF Spampinato, GI Caruso, R De Pasquale… - Pharmaceuticals, 2020 - mdpi.com
Chronic wounds often occur in patients with diabetes mellitus due to the impairment of
wound healing. This has negative consequences for both the patient and the medical …

[HTML][HTML] ESVM Guideline on peripheral arterial disease

U Frank, S Nikol, J Belch, V Boc, M Brodmann… - Vasa, 2019 - econtent.hogrefe.com
The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …

Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice

C Li, H Zhao, L Cheng, B Wang - Cell & Bioscience, 2021 - Springer
Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment
of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from …

Mesenchymal stem cells and immunomodulation: current status and future prospects

F Gao, SM Chiu, DAL Motan, Z Zhang, L Chen… - Cell death & …, 2016 - nature.com
The unique immunomodulatory properties of mesenchymal stem cells (MSCs) make them
an invaluable cell type for the repair of tissue/organ damage caused by chronic inflammation …

Managing diabetic foot ulcers: pharmacotherapy for wound healing

D Dixon, M Edmonds - Drugs, 2021 - Springer
Historically, there has been a scarcity of evidence-based topical therapy to hasten the
healing of diabetic foot ulcers. But recently new evidence-based treatments have emerged …

Hypoxia inducible factor-1α potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes

H Gonzalez-King, NA García, I Ontoria-Oviedo… - Stem …, 2017 - academic.oup.com
Insufficient vessel growth associated with ischemia remains an unresolved issue in vascular
medicine. Mesenchymal stem cells (MSCs) have been shown to promote angiogenesis via a …

[HTML][HTML] Diabetic foot ulcer: Challenges and future

L Yang, GC Rong, QN Wu - World journal of diabetes, 2022 - ncbi.nlm.nih.gov
Diabetic foot ulcers (DFUs) have become one of the important causes of mortality and
morbidity in patients with diabetes, and they are also a common cause of hospitalization …